The update of the S-scan magnetic resonance imaging (MRI) system reportedly offers an improved ergonomic design, algorithms to enhance image quality and reduced scan times.
Offering a variety of technological improvements to help facilitate optimal imaging and radiology workflows, Esaote has introduced the S-scan Open magnetic resonance imaging (MRI) system, an update to the company’s established S-scan MRI platform.
Esaote said the system’s combination of image acquisition and reconstruction capabilities through technologies such as SpeedUp and TR reduction enables clinicians to reduce artifacts, background noise and scan times. The combination of True-Motion technology with the S-scan Open MRI’s open magnet design allows one to capture real-time images of joint movements, according to Esaote.
The company adds that a complete set of RF coils, included with the S-scan Open MRI system, may facilitate improved spatial resolution, a high signal-to-noise ratio (SNR) and maximum sensitivity to anatomies being imaged.
Esaote added that key ergonomic features of the MRI system include a wide asymmetric rotating table, which promotes easy setup as well as maximum comfort and stability with patient positioning.
‘With S-scan Open, we have relied on Esaote’s latest technology in terms of the hardware and software platform. It has been specifically reengineered to face the challenging requirements of musculoskeletal exams,” said Massimo Olmi, the MRI marketing director of Esaote.
Breast MRI and Dense Breasts: A Closer Look at Early Findings from a New Prospective Trial
May 2nd 2024Supplemental breast MRI had a cancer detection rate (CDR) of 20/1000 and a positive predictive value (PPV) of 50 percent, according to preliminary findings from a prospective trial involving women with heterogeneously or very dense breasts.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.